Leading the way to safer medication

Azacitidine

Azacytidine

ONUREG VIDAZA

Description

Azacitidine is believed to exert its antineoplastic effects by multiple mechanisms including cytotoxicity on abnormal haematopoietic cells in the bone marrow and hypomethylation of DNA.

ATC Classification

Code
Title
Category
L01BC07
Azacitidine
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues

Related medicines

MPI, EU: SmPC 2019: SPC: VIDAZA Powder for suspension for injection
MPI, EU: SmPC 2012: SPC, UK: Vidaza 25 mg/ml powder for suspension for injection

2D Molecule Structure

Unique Ingredient Identifier (UNII)

M801H13NRU - AZACITIDINE

CAS Registry Number

320-67-2 - azacitidine

SNOMED-CT

412328000 - Azacitidine (substance)

 
Next: Usage >